Last updated: 5 September 2024 at 4:33pm EST

Richard A. Paulson M.B.A. Net Worth




The estimated Net Worth of Richard A. Paulson is at least $1.53 Million dollars as of 4 September 2024. Mr Paulson owns over 3,667 units of Karyopharm Therapeutics Inc stock worth over $843,018 and over the last 5 years he sold KPTI stock worth over $639,595. In addition, he makes $52,377 as Pres and CEO & Director at Karyopharm Therapeutics Inc.

Mr A KPTI stock SEC Form 4 insiders trading

Mr has made over 31 trades of the Karyopharm Therapeutics Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he sold 3,667 units of KPTI stock worth $2,640 on 4 September 2024.

The largest trade he's ever made was selling 99,844 units of Karyopharm Therapeutics Inc stock on 29 February 2024 worth over $117,816. On average, Mr trades about 6,830 units every 22 days since 2020. As of 4 September 2024 he still owns at least 1,139,214 units of Karyopharm Therapeutics Inc stock.

You can see the complete history of Mr Paulson stock trades at the bottom of the page.





Mr. Richard A. Paulson M.B.A. biography

Richard A. Paulson M.B.A. is the Pres, CEO & Director at Karyopharm Therapeutics Inc.

What is the salary of Mr A?

As the Pres and CEO & Director of Karyopharm Therapeutics Inc, the total compensation of Mr A at Karyopharm Therapeutics Inc is $52,377. There are 16 executives at Karyopharm Therapeutics Inc getting paid more, with Ran Frenkel having the highest compensation of $6,481,860.



How old is Mr A?

Mr A is 54, he's been the Pres and CEO & Director of Karyopharm Therapeutics Inc since . There are 11 older and 12 younger executives at Karyopharm Therapeutics Inc. The oldest executive at Karyopharm Therapeutics Inc is Garen Bohlin, 72, who is the Independent Director.

What's Mr A's mailing address?

Richard's mailing address filed with the SEC is C/O KARYOPHARM THERAPEUTICS INC., 85 WELLS AVENUE, NEWTON, MA, 02459.

Insiders trading at Karyopharm Therapeutics Inc

Over the last 11 years, insiders at Karyopharm Therapeutics Inc have traded over $149,223,596 worth of Karyopharm Therapeutics Inc stock and bought 562,763 units worth $10,312,371 . The most active insiders traders include Deepika Pakianathan, Ltd Czernik Marcin Hadjimic..., and Mikael Dolsten. On average, Karyopharm Therapeutics Inc executives and independent directors trade stock every 12 days with the average trade being worth of $26,350. The most recent stock trade was executed by Michael Mano on 4 September 2024, trading 3,971 units of KPTI stock currently worth $2,859.



What does Karyopharm Therapeutics Inc do?

karyopharm therapeutics inc. is a clinical-stage pharmaceutical company focused on discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. for more information, please visit www.karyopharm.com



What does Karyopharm Therapeutics Inc's logo look like?

Karyopharm Therapeutics Inc logo

Complete history of Mr Paulson stock trades at Bluebird bio Inc and Karyopharm Therapeutics Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
4 Sep 2024 Richard A. Paulson
President and CEO
Sale 3,667 $0.72 $2,640
4 Sep 2024
1,139,214
6 Aug 2024 Richard A. Paulson
President and CEO
Sale 3,608 $0.93 $3,355
6 Aug 2024
1,142,881
5 Jul 2024 Richard A. Paulson
President and CEO
Sale 3,616 $0.85 $3,074
5 Jul 2024
1,146,489
4 Jun 2024 Richard A. Paulson
President and CEO
Sale 3,592 $0.99 $3,556
4 Jun 2024
1,150,105
6 May 2024 Richard A. Paulson
President and CEO
Sale 3,576 $1.13 $4,041
6 May 2024
1,153,697
4 Apr 2024 Richard A. Paulson
President and CEO
Sale 3,563 $1.29 $4,596
4 Apr 2024
1,157,273
5 Mar 2024 Richard A. Paulson
President and CEO
Sale 3,573 $1.30 $4,645
5 Mar 2024
1,160,836
29 Feb 2024 Richard A. Paulson
President and CEO
Sale 99,844 $1.18 $117,816
29 Feb 2024
1,164,409
6 Feb 2024 Richard A. Paulson
President and CEO
Sale 4,012 $1.59 $6,379
6 Feb 2024
821,453
4 Jan 2024 Richard A. Paulson
President and CEO
Sale 4,114 $0.82 $3,373
4 Jan 2024
783,465
4 Dec 2023 Richard A. Paulson
President and CEO
Sale 3,622 $0.79 $2,861
4 Dec 2023
787,579
6 Nov 2023 Richard A. Paulson
President and CEO
Sale 3,606 $0.92 $3,318
6 Nov 2023
791,201
4 Oct 2023 Richard A. Paulson
President and CEO
Sale 3,589 $1.27 $4,558
4 Oct 2023
794,807
5 Sep 2023 Richard A. Paulson
President and CEO
Sale 3,622 $1.33 $4,817
5 Sep 2023
798,396
7 Aug 2023 Richard A. Paulson
President and CEO
Sale 3,722 $1.72 $6,402
7 Aug 2023
802,018
5 Jul 2023 Richard A. Paulson
President and CEO
Sale 3,538 $1.72 $6,085
5 Jul 2023
805,740
5 Jun 2023 Richard A. Paulson
President and CEO
Sale 3,536 $2.24 $7,921
5 Jun 2023
809,278
4 May 2023 Richard A. Paulson
President and CEO
Sale 3,805 $3.35 $12,747
4 May 2023
812,814
4 Apr 2023 Richard A. Paulson
President and CEO
Sale 3,497 $3.97 $13,883
4 Apr 2023
816,619
6 Mar 2023 Richard A. Paulson
President and CEO
Sale 3,506 $3.16 $11,079
6 Mar 2023
820,116
28 Feb 2023 Richard A. Paulson
President and CEO
Sale 33,033 $3.03 $100,090
28 Feb 2023
823,622
6 Feb 2023 Richard A. Paulson
President and CEO
Sale 3,950 $3.40 $13,430
6 Feb 2023
604,655
4 Jan 2023 Richard A. Paulson
President and CEO
Sale 3,922 $3.27 $12,825
4 Jan 2023
608,605
5 Dec 2022 Richard A. Paulson
President and CEO
Sale 3,490 $5.17 $18,043
5 Dec 2022
612,527
4 Nov 2022 Richard A. Paulson
President and CEO
Sale 3,493 $4.54 $15,858
4 Nov 2022
616,017
4 Oct 2022 Richard A. Paulson
President and CEO
Sale 3,488 $5.87 $20,475
4 Oct 2022
619,510
8 Sep 2022 Richard A. Paulson
President and CEO
Sale 3,479 $5.23 $18,195
8 Sep 2022
622,998
4 Aug 2022 Richard A. Paulson
President and CEO
Sale 2,314 $4.48 $10,367
4 Aug 2022
626,477
8 Jul 2022 Richard A. Paulson
President and CEO
Sale 2,115 $5.18 $10,956
8 Jul 2022
628,791
7 Jun 2022 Richard A. Paulson
President and CEO
Sale 2,542 $5.76 $14,642
7 Jun 2022
630,906
4 May 2022 Richard A. Paulson
President and CEO
Sale 28,502 $6.23 $177,567
4 May 2022
633,448


Karyopharm Therapeutics Inc executives and stock owners

Karyopharm Therapeutics Inc executives and other stock owners filed with the SEC include: